SelectQuote (NYSE:SLQT - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03, Zacks reports. SelectQuote had a negative net margin of 4.33% and a negative return on equity of 11.44%. The business had revenue of $376.40 million during the quarter, compared to analyst estimates of $341.80 million. During the same period in the prior year, the business earned $0.06 EPS. SelectQuote updated its FY 2024 guidance to EPS.
SelectQuote Trading Up 1.4 %
SelectQuote stock traded up $0.04 during mid-day trading on Friday, hitting $2.63. The company had a trading volume of 1,238,159 shares, compared to its average volume of 560,866. SelectQuote has a 12 month low of $1.03 and a 12 month high of $3.06. The company has a market capitalization of $443.60 million, a PE ratio of -8.47 and a beta of 0.80. The stock's 50 day moving average price is $1.84 and its two-hundred day moving average price is $1.51.
Analyst Ratings Changes
Separately, Noble Financial started coverage on shares of SelectQuote in a research report on Thursday, February 29th. They set an "outperform" rating and a $5.00 price target for the company.
Get Our Latest Analysis on SelectQuote
About SelectQuote
(
Get Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Further Reading
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
